Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
primary studies published RCT
Details- 2002
- Hordvik NL
Effect of growth hormone on exercise tolerance in children with cystic fibrosis.
primary studies published RCT
Details- 2002
- Hütler M
A widely available method for the assessment of aerosol delivery in cystic fibrosis.
primary studies published RCT
Details- 2002
- Kastelik JA
A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
primary studies published RCT
Details- 2002
- Ledson MJ
Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Lepage G
The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- McKone EF
Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Moss RB
Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres--an open randomised crossover preference study.
primary studies published RCT
Details- 2002
- Patchell CJ
Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection.
primary studies published RCT
Details- 2002
- Quittner AL
Effect of a microaerosol filter on spirometry in children with cystic fibrosis.
primary studies published RCT
Details- 2002
- Rogers D